Stock Option Investment Advice

What’s Up With Omnicare?

Call option volume for Omnicare (OCR) was significantly up today, and there does not appear to be any related news. Omincare’s stock price was also little changed from Friday’s close.

Omnicare is in the pharmaceutical services business targeting the geriatric market segment. The company provides a wide range of products and services including pharmacy services to nursing facilities and assisted living communities.

OCR

Omnicare’s competitors include PharMerica (PMC), Covenant Care (private) and Option Care (private).

OCR Chart

Omnicare’s stock price has been stuck in a trading range between $20 and $30 over the last year. Omincare’s stock price has been in a slide over the last four months and its stock price took a big hit near the end of July as the company cut is profit outlook.

Omnicare’s October 22.5 call option saw significant volume today. This call option is out-of-the-money and is due to expire in only 5 days. This is a very bullish indicator. The November 22.5 call option also saw an increase in volume today.

Sign up now for PowerOptions 14-day free trial

The Strike of Pain for Omnicare is also very bullish with the strike of pain at 22.50 for October. The Strike of Pain represents the strike where the options buyers will lose the most money and the option sellers will gain the most money at expiration.

OCR SOF Chart

So what’s up with Omnicare? Omnicare’s earnings report is not due until 11/5/2009, which is a little early to see this kind of call option volume, especially for the October 22.5 call options which expire before the earnings report on 11/5/2009. Maybe one of the big drugstore companies has their eye on Omnicare, CVS Caremark (CVS), Rite Aid (RAD), Walgreen (WAG) or Walmart (WMT)?

See what the stock option experts are doing
Sign up now for PowerOptionsApplied 30-day risk free trial

A covered call investing position for Omnicare for November expiration looks attractive with a %if unchanged potential return of 4.1% and a %if assigned potential return of 8.7%. The timeframe for potentially realizing these returns is only 40 days. The call option to sell would be the November 22.50 with a ticker symbol of OCRKX.

Free stock option newsletter
» return goal > 2% / month
» works in any market

To enter the covered call investing position an investor would purchase the stocks in multiples of 100 shares and sell one call option for each 100 shares of stock purchased.

For more information about how to identify and research great option trades, visit the PowerOptions website. There you will find the data you need to make quick, clear, and informed decisions. You can trade knowing you have found the best investment. Also, PowerOptions will allow you, with a few quick clicks, to quickly and accurately compare trades. PowerOptions’ premium customer support is second to none in the industry. They can be easily contacted when you need them at their toll-free number to answer customer questions. Call them now toll free at 877-992-7971.

Want to protect your portfolio/401K from market downside?
yet still benefit from market upside
Sign up now for the free Sketch

PowerOptions provides a free 14-day trial of its service. So join PowerOptions today, and you too can start reaping the benefits of the covered call investment strategy.

Learn how to profit from winner stocks
and protect yourself from loser stocks
Download free Trade Simulator now

PowerOptions’ sister company PowerOptionsApplied provides expert stock option trading recommendations. PowerOptionsApplied specializes in covered calls, naked puts and iron condor stock options strategy recommendations. PowerOptionsApplied provides a 30-day risk free trial of its service.

Learn to trade like the pros
Signup for free Webinars now

[tags] pharmaceutical services, geriatric, nursing facilities, assisted living communities, CVS, CVS Corp., OCR, Omnicare Inc., PMC, Pharmerica Corp., RAD, Rite Aid Corp., WAG, Walgreen Co., WMT, Wal-Mart Stores Inc. [/tags]

Leave a Reply

Your email address will not be published. Required fields are marked *